Paysafe (NYSE:PSFE) 주식

Paysafe

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

Entertainment

Asset Sales

Media

AMPS

BLCO

GRAB

NSANY

PCHM

PSFE

Sony Group Corporation American Depositary Shares

SONY

TYO:4188

블록에 등장한 신규 기업들팜켐(OTC:PCHM), 약물 감지 땀 패치의 대표 기업이 전략적 대안을 모색하고 있다(즉, 인수합병 또는 매각). 이사회는 지금까지 은행가를 고용하는 것보다 독자적으로 상황을 처리할 수 있다고 자신감을 나타냈다. 관심 있는 인수자는 공식 데이터룸에 접근할 수 있다.

딜 디스패치: 팜켐이 독자 매각을 진행, TGI 프라이데이는 $1,900만 에 19개의 레스토랑 매각

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

KYTX

RMBL

화요일 오전(현지 시간 기준) 미국 주식 선물이 상승하면서 오늘 투자자들의 관심을 끌 수 있는 주식 중 일부는 다음과 같다: 월가는 홈 디포(NYSE:HD)가 개장 전에 분기별 이익을 주당 4.50달러, 매출 433억 8천만 달러로 보고할 것으로 예상하고 있다. 홈디포 주가는 시간외 거래에서 0.2% 상승한 346.59달러를 기록했다.

화요일 주목해야 할 주식: 홈 디포, 페이세이프 그리고 3종목

Paysafe Ltd

Paysafe Limited Warrants, exercisable for one Common Share of Paysafe Limited at a price of $11.50 per share

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates Unity Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBX#NASDAQ">UBX</a>) with a Buy and maintains $8 price target.

Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Unity Biotechnology, Maintains $8 Price Target

The acquisition marks a significant step in NETCLASS' strategy to expand its market across Asia. It provides the Company with a new operational center in Tokyo, Japan, and signifies the Company's dedication to its long-term plan through enhancing its software development capability, improving the quality of existing products, and diversifying its customer base

NTCL

NETCLASS TECHNOLOGY Enters Japan Market Via Strategic Acquisition Of Createsolutions; Eyes Regional Growth And Innovation

Today, during TMC's 2025 Annual Meeting &amp; Transportation Technology Exhibition, <a href="https://www.globenewswire.com/Tracker?data=oIBFlhCGj2iyGabzNvH-QtyhXc01zojN8oJuOF7d4khNcCYSVMrKSahqpheVBRVrOBV8ah7WHFnXKLTQJS6ODuT6rH1mclWPco71lhbyDaDAAn69LrrIKnMFs2hsjI20yxrpHrNKmxreMvlYbcPO-oieXFvpAsat3VPHRU7V4jvkIU2qZIMVNJ00iHMDyLADb13xqQhrUWHPtd1ORaAp25AKvE6YIxr4dbbyGx9Qtc5sUtkwcYPFVC-cgVwlPNLwPpINCtaUct3ZJtImL0Or0zzr8hVBjtLYfjHaWM0Nx8R2x5wLpDul2ePtqXN2uFZYAutho7AHfx5vGat2_46S1Ae3YYgRTa2jqdqqDNZvhhq2p35254qxfc2DE211stlDK4XRRD0kWV3DWbhnNaDLEw==">Dragonfly Energy Holdings Corp.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and battery technology, unveiled the new Battle Born&#xAE; DualFlow Power Pack. This innovative lithium power system is designed to eliminate idle time and alleviate strain on starter batteries by providing dedicated power for hotel loads in long haul trucks. Engineered for universal compatibility, the DualFlow Power Pack installs inside the sleeper cab under the bunk without any modifications to existing systems.
The DualFlow Power Pack powers auxiliary loads while the truck is parked by removing cycles from the starter batteries and extending the lifespan while reducing unnecessary engine starts. Once the truck is back in motion, it recharges using Wakespeed&#xAE; Charge Control Technology, making use of available energy without additional fuel consumption. Designed for Heavy-Duty Trucking fleets and owner-operators with sleeper cabs, it is particularly well-suited for fleets that do not use auxiliary air conditioners. With a low price point and an ROI well under a year, the Company believes fleets can quickly recover their investment and witness significant real-world savings in fuel costs, battery replacements, and maintenance.

DFLI

Dragonfly Energy Unveils DualFlow Power Pack to Cut Truck Idle Time, Save Fuel

This is inclusive of non-recurring first-of-a-kind, Project Permian site-specific and owner costs. Provided the successful value engineering process, the project would come online no earlier than 2029.

NPWR

Net Power Now Estimates Project Permian's Total Installed Cost To Be Between $1.7B And $2.0B

Citigroup analyst Spiro Dounis upgrades Pembina Pipeline (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PPL#TSX">PPL</a>) from Neutral to Buy and announces C$63 price target.

Upgrades

TSX:PPL

Citigroup Upgrades Pembina Pipeline to Buy, Announces C$63 Price Target

CYTK

Cytokinetics Said Maintain Expectation For Differentiated Label & Risk Mitigation Profile For Aficamten, If Approved By FDA

<ul>
<li>ARO-C3 achieved deep and sustained reductions in alternative pathway complement activity and proteinuria.</li>
<li>Mean sustained reductions in C3 of ≥87%, AH50 of ≥76%, Wieslab AP of ≥89% through week 24.</li>
<li>Mean reduction in spot urine protein-to-creatinine ratio (UPCR) of 41% by week 24</li>
</ul>

Biotech

Health Care

General

ARWR

Arrowhead Pharmaceuticals Announced Topline Results From Part 2 Of A Phase 1/2 Study Of ARO-C3 To Reduce Liver Production Of Complement Component 3 As A Potential Therapy For Various Complement Mediated Diseases

Management

OPRX

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer, Effective Mar. 10

<a href="https://www.globenewswire.com/Tracker?data=R6VVCCZIhiwgUK0Su5g-03QsiEEun8cdd7B68fBQab3f-o8XagXSGpWRxYbe3KXmnxg4V22ck5WnzOKfP9JaPJm6lt1rWMx8tCLg6zAAzG4=">Plus Therapeutics</a>, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced that on March 7, 2025 the Company received confirmation from Nasdaq that the Company has regained compliance with Nasdaq's minimum stockholders' equity requirement. The Company's common stock will continue to be listed and traded on The Nasdaq Capital Market.

Government

Regulations

PSTV

Plus Therapeutics Regains Nasdaq Compliance, Keeps Stock Listed on Capital Market

BEKE

KE Holdings Class A Ordinary Shares Traded On Hong Kong Stock Exchange Have Been Included In Hong Kong Stock Connect And Shenzhen-Hong Kong Stock Connect Programs

Net Power Says It Closed 2024 With $533M In Cash, Cash Equivalents, And Investments, Down From $580M Last Quarter

Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) reported quarterly earnings of $0.24 per share. This is a 35.14 percent decrease over earnings of $0.37 per share from the same period last year. The company reported $102.90 million in sales this quarter. This is a 1.91 percent decrease over sales of $104.90 million the same period last year.

Genie Energy Q4 2024 GAAP EPS $0.24 Down From $0.37 YoY, Sales $102.90M Down From $104.90M YoY

Dividends

Buybacks

AMAT

Applied Materials Announces $10B Share Repurchase Authorization And Raises Dividend From $0.40 To $0.46/Share

On Friday, March 7th, U.S. markets closed higher after rebounding from early losses, following remarks by Federal Reserve Chair Jerome Powell that the economy remains &#8220;in a good place.&#8221; However, he cautioned against expecting rapid interest rate cuts, emphasizing a cautious approach.
Despite the late-week rally, persistent uncertainty over U.S. trade policy—especially concerning tariffs on imports from Canada, Mexico, and China—contributed to the S&amp;P 500&#8217;s recording its worst weekly performance since September.
In economic data, February&#8217;s jobs report showed the U.S. added 151,000 jobs—up from January but below the 160,000 forecast. The unemployment rate unexpectedly rose to 4.1%, slightly above the 4.0% estimate.
Most S&amp;P 500 sectors rose Friday, led by utilities, tech, and energy, while consumer staples and financials declined.
The Dow Jones Industrial Average rose 0.54% to close at 42,801.72, the S&amp;P 500 gained 0.55% to 5,770.20, and the Nasdaq Composite was up 0.70% to 18,196.22.
Asia Markets Today
<ul>
<li>On Monday, Japan&#8217;s Nikkei 225 gained 0.34% to 36,990.00, led by gains in the Power, Rubber and Chemical, Petroleum &amp; Plastic sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 rose 0.18%, closing at 7,962.30, led by gains in the Energy, Gold and Resources sectors.</li>
<li>India&#8217;s Nifty 50 was down 0.49% to 22,441.10, while the Nifty 500 slipped 1.02% to 20,234.80.</li>
<li>China&#8217;s Shanghai Composite declined 0.19% to 3,366.16, and the Shanghai Shenzhen CSI 300 fell 0.39% to 3,928.80.</li>
<li>Hong Kong&#8217;s Hang Seng fell 1.85%, ending the session at 23,783.49.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 was down 0.70%.</li>
<li>Germany&#8217;s DAX declined 0.71%.</li>
<li>France&#8217;s CAC fell 0.39%.</li>
<li>U.K.&#8217;s FTSE 100 index traded lower by 0.40%</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.27% at $67.22/bbl, and Brent was up 0.28% at $70.57/bbl.</li>
<li>Oil prices steadied Monday amid tariff uncertainty, rising OPEC+ output, and weak global demand. WTI marked its seventh weekly loss, while Brent fell for a third straight week.</li>
<li>Natural Gas gained 4.35% to $4.588.</li>
<li>Gold was trading higher by 0.06% at $2,915.81, Silver was up 0.64% to $33.020, and Copper slipped 0.62% to $4.6805.</li>
</ul>
U.S. Futures at 06:00 AM ET
<ul>
<li>Dow futures were down 0.80%, S&amp;P 500 futures fell 1.00% and Nasdaq 100 futures slid 1.15%.</li>
<li>U.S. stock futures fell Monday amid tariff uncertainty, recession fears, and weak Chinese inflation data.</li>
</ul>
Forex at 06:00 AM ET
The U.S. Dollar Index slipped 0.14% to 103.70, USD/JPY was down 0.64% to 147.08, and USD/AUD declined 0.30% to 1.5811.
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Market Mixed, Europe Dips; US Futures Slide On Slowdown Fears - Global Markets Today While US Slept

RKT: -10% &#x7C; <a href="https://www.benzinga.com//node/44215917">Rocket Companies shares are trading lower after the company announced it will acquire Redfin in an all-stock transaction valued at $12.50 per share.</a>
&nbsp;
MLYS: 34% &#x7C; <a href="https://www.benzinga.com//node/44215943">Mineralys Therapeutics shares are trading higher after the company reported topline data from its pivotal LAUNCH-HTN Phase 3 and ADVANCE-HTN Phase 2 trials of Lorundrostat for hypertension. Both trials met the primary endpoint.</a>
&nbsp;
TRVI: 41% &#x7C; <a href="https://www.benzinga.com//node/44215929">Trevi Therapeutics shares are trading higher after the company reported topline results from its Phase 2a RIVER trial of Haduvio for RCC, which met the primary endpoint.</a>

Movers

MLYS

TRVI

Market-Moving News for March 10th

U.S. stock futures declined on Monday after a small bout of relief on Friday as indices neared the correction zone. Futures of all four benchmark indices fell in premarket trading.
President Donald Trump, on Sunday, did not rule out the possibility of a recession this year. Acknowledging the potential of short-term turbulence from his economic agenda, he expressed confidence in future prosperity. In a Fox News interview, he said, &#8220;I hate to predict things like that&#8221; and called the changes being brought about by his administration as &#8220;very big.&#8221;
Meanwhile, China responded with retaliatory tariffs on U.S. agricultural goods including its largest import from the U.S. — Soybeans.
Investors will watch out for the inflation data slated to be released this week on Wednesday.
Meanwhile, the 10-year Treasury yield stood at 4.24%, while the two-year yield was at 3.94%. According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is a 97% chance that the Federal Reserve will keep interest rates unchanged for the March meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-1.22%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.15%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.95%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.04%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Monday. SPY lost 1.03% to fall at $570.00 level, and QQQ declined 1.12% to $486.26, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Utilities, information technology, and energy sectors led Friday&#8217;s U.S. <a href="https://www.benzinga.com/news/earnings/25/03/44212927/dow-gains-over-200-points-but-records-weekly-loss-fear-among-investors-eases-but-greed-index-remains-in-extreme-fear-zone">stock gains</a>, pushing the Dow Jones over 200 points higher. However, consumer staples and financials declined, countering the broader market&#8217;s positive trend. 
Despite Friday&#8217;s rally, all major indices recorded weekly losses: the S&amp;P 500 fell 3.1%, its worst week since September, the Dow dropped 2.4%, and the Nasdaq tumbled 3.5%. Last week, Nasdaq 100 entered the correction territory on Friday, falling nearly 10% from its last high, which eased to 9.1% after Friday&#8217;s sessions, whereas the S&amp;P 500 was 6.1% lower from its last record.
Economic data revealed a mixed picture, with February&#8217;s jobs report showing a moderate increase of 151,000 jobs, below expectations, and a surprise rise in the unemployment rate to 4.1%.
In company news, Genesco Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCO#NYSE">GCO</a>) shares plummeted over 16% on disappointing earnings, while American Public Education Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) shares surged 22% on strong results.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.70%</td>
<td>18,196.22</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.55%</td>
<td>5,770.20</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.52%</td>
<td>42,801.72 </td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.43%</td>
<td>2,075.48</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
According to the Yardeni Research&#8217;s QuickTakes by Ed Yardeni and Eric Wallerstein, &#8220;Anything is possible in Trump World.&#8221;
&#8220;We can&#8217;t rule out the possibility that a bear market started on Feb. 20, the day after the S&amp;P 500 rose to a record high. It could be like the &#8216;flash crashes&#8217; that occurred during 1962 and 1987. It could happen quickly and reverse just as quickly. So the selloff could provide buying opportunities, especially in overvalued names that are now less so,&#8221; the note stated.
According to the note, Trump administration&#8217;s rapid-fire policy initiatives are stress-testing the economy, which has been remarkably resilient so far, and raising fears of a recession.
The current bull market, which began in October 2022, has entered its third year. According to Ryan Detrick, the chief market strategist at Carson Research, it is normal to see some fluctuations in the third year of a bull market.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Not all bull markets make it to their third year, but when they do it is perfectly normal to see some chop and frustration. <a href="https://t.co/moLsIkXAhS">pic.twitter.com/moLsIkXAhS</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1898930376824803647?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
While the conflict around tariffs has raised the speculation of a slowdown and recession, Louis Navellier of Navellier &amp; Associates had a contrarian view. According to him, &#8220;The anxiety over tariffs may be holding back some consumers, but I want to assure you that I do not expect most tariffs to be inflationary. As an example, the tariffs that have been imposed on China are expected to be suppressed by Chinese deflation as well as a weak Chinese yuan.&#8221;
See Also:<a href="https://www.benzinga.com/money/how-to-trade-futures"> How to Trade Futures</a>
Upcoming Economic Data
Here&#8217;s what investors will keep on this week:
<ul>
<li>No data is scheduled to be released on Monday.</li>
</ul>
<ul>
<li>On Tuesday, February&#8217;s NFIB optimism index data will be released at 6:00 a.m., ET.</li>
</ul>
<ul>
<li>January&#8217;s job openings data will be out by 10:00 a.m., ET.</li>
</ul>
<ul>
<li>On Wednesday, February&#8217;s core and headline consumer price index data will be out by 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Monthly U.S. federal budget data for February will be announced at 2:00 p.m., ET.</li>
</ul>
<ul>
<li>On Thursday, the initial jobless claims data for the week ended March 8 will be released at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>The core and headline producer price index data for February will also be announced at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>On Friday, the preliminary consumer sentiment data for March will be released by 10:00 a.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>BioNTech SE ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) slipped 1.06% in premarket on Monday ahead of its earnings, which will be released before the opening bell. Analysts expect it to report earnings of 58 cents per share on revenue of $1.15 billion.</li>
</ul>
<ul>
<li>Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) dropped 1.44% as Wall Street expects it to report quarterly earnings of $1.49 per share and revenue of $14.40 billion after the closing bell.</li>
</ul>
<ul>
<li>Mission Produce Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVO#NASDAQ">AVO</a>) was down 0.33% ahead of its earnings, which will be released after the closing bell. Analysts expect it to report earnings of 3 cents per share on revenue of $285.50 million.</li>
</ul>
<ul>
<li>Vail Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) was flat at -0.01% as Wall Street expects it to report quarterly earnings of $6.31 per share on revenue of $1.14 billion after the closing bell.</li>
</ul>
<ul>
<li>Cognizant Technology Solutions Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSH#NASDAQ">CTSH</a>) jumped by 3.33% following a report on Friday suggesting activist investor, Mantle Ridge, built a more than $1 billion stake in the company.</li>
</ul>
<ul>
<li>Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) declined 1.41% despite posting a year-on-year rise in its February 2025 revenue. The sales fell on a monthly basis from January by 11.3%.</li>
</ul>
<ul>
<li>Checkpoint Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CKPT#NASDAQ">CKPT</a>) surged 66.40% after Sun Pharma acquired the company for up to $355 million, securing FDA-approved cancer drug UNLOXCYT.</li>
</ul>
<ul>
<li>Sharps Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) zoomed 62.15% after providing business updates. The company raised $20 million, cleared its debt and expanded in Hungary. Also signed a five-year, $50 million syringe deal with a U.S. supplier, which is set to begin revenue generation in the second half of 2025.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 0.04% to hover around $67.02 per barrel.
The gold spot index was up by 0.28% to $2,903.10 per ounce. Its last record high was at $2,956.37 per ounce. The Dollar Index was down 0.20% at the 103.628 level.
Asian markets closed mixed on Monday as Australia's ASX 200, Japan's Nikkei 225, and South Korea's Kospi index advanced, whereas China's CSI 300, and Hong Kong's Hang Seng index declined. European markets were lower in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44214169/mark-zuckerbergs-meta-platforms-a-lucrative-bet-as-investors-favor-less-leveraged-tech-stocks-says-expert-amid-mag7s-2025-underperformance">Mark Zuckerberg&#8217;s Meta Platforms A Lucrative Bet As &#8216;Investors Favor Less Leveraged Tech Stocks,&#8217; Says Expert Amid Mag7&#8217;s 2025 Underperformance</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Economics

APEI

BNTX

CKPT

CTSH

ORCL

STSS

US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory

Clearmind Medicine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the publication of a patent by the Korean Intellectual Property Office (KIPO), South Korea's official patent and intellectual property authority. The patent covers the Company's innovative combination therapy of MEAI and N-Acylethanolamines for the treatment of cocaine addiction.
The patent is based on preclinical trial results led by Professor Gal Yadid and his team at the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University in Israel. These studies build upon earlier experiments in which animals treated with MEAI exhibited a significant reduction in cocaine-induced cravings.
Further research was conducted in rats to assess whether MEAI's effects on drug-seeking behavior extended to natural rewards, given that reward-based reinforcement is a fundamental survival mechanism across species. The study produced positive results, demonstrating that while MEAI reduced cocaine-seeking behavior, it did not impair the rats' response to natural rewards such as sucrose. This finding suggests that MEAI's impact on drug cravings is not tied to the general reward system but is specifically targeted at drug-related compulsions.
This pioneering research has led to multiple patent applications in the U.S. and other global jurisdictions and is part of Clearmind's ongoing collaboration with SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>) ("SciSparc"), a specialty clinical-stage pharmaceutical company focused on developing therapies for central nervous system disorders. The collaboration aims to combine Clearmind's MEAI, a novel proprietary psychedelic treatment for addiction and mental health, with SciSparc's PEA

CMND

SPRC

Clearmind Wins South Korea Patent for Psychedelic Therapy Targeting Cocaine Addiction

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10080426/Cango-0310-01.jpeg" alt="" class="wp-image-7456" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10080426/Cango-0310-01.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10080426/Cango-0310-01-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10080426/Cango-0310-01-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The company, whose main business was previously auto trading, said its revenue skyrocketed in the fourth quarter after its move into bitcoin mining
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul>
<li>Cango's revenue rose more than fivefold to 668 million yuan in last year's fourth quarter, following its launch of a bitcoin mining operation last November</li>
<li>The company will add 18 EH of new capacity by the end of this quarter, bringing its total to 50 EH, making it the world's second-largest bitcoin miner</li>
</ul>
There's nothing like a new business model to put some new spring into your step.
After watching its revenue dwindle for a year and a half,&nbsp;Cango Inc.&nbsp;(CANG.US) came roaring back in the final quarter of last year, following a major shift into the cryptocurrency mining business in November. This was no subtle shift either. The company's revenue skyrocketed by more than a factor of five to 668 million yuan ($92 million) for the quarter from 130.2 million yuan a year earlier.
The latest figure not only marked Cango's first year-on-year revenue growth since the second quarter of 2023, but was also its highest total since that quarter. And in one final impressive feat, the figure was light years ahead of the company's forecast just three months earlier for fourth-quarter revenue of just 15 million yuan to 17.5 million yuan – quite possibly the biggest revenue "beat" of all time for any company.
The crypto shift looks set to continue for Cango, which announced a major expansion to its mining capacity in the current quarter and the potential for more in the second half of the year. The company is also aware of the risks of tying its fate to such a volatile sector, and broadly discussed some of the steps it is taking to control such risk. As a newcomer to the industry, Cango is also still on a sharp learning curve, which is reflected in its relatively high costs for each bitcoin it mines compared with some older peers. Those higher costs also owe to Cango's asset-light business model that differs from many of its peers by requiring much lower up-front investment, but with higher operating costs.
The sudden revenue jolt owes completely to Cango's move into cryptocurrency in November. Before that, the company was engaged in the auto business, first as a car loan financier, and more recently as a provider of domestic and international car trading services. That was fine when China's car industry was booming for most of the 21st&nbsp;century, as it zipped past the U.S. to become the world's largest market.
But the market has become stuck in slow-growth mode over the last few years as China's economy slows, resulting in huge overcapacity built up over the boom years. That's led to endless price wars with most companies losing money, leading Cango to scale down its car business to avoid falling into the same trap.
Reaction to Cango's latest report after its release last Thursday was relatively muted, with its shares rising 2.1% the next day. The stock has doubled over the last six months since Cango first announced the move into crypto mining in early November. But notably, the shares are also down 28% so far this year, tracking an 8% drop for bitcoin, showing the company's future will inevitably follow bitcoin prices to some extent.
Reflecting its newness to the industry, Cango's shares currently trade at a relatively low forward price-to-earnings (P/E) ratio of between 4 and 8, based on our calculations using its likely profit for this year derived from its fourth-quarter performance. That's well behind the ratio of 40 for industry leader&nbsp;Mara&nbsp;(MARA.US). Better comparisons might be&nbsp;Cipher&nbsp;(CIFR.US) and&nbsp;Bitfufu&nbsp;(FUFU.US), which trade higher than Cango with P/E ratios of 12, implying Cango's stock could still have some upside as more investors discover the company.
<h4 class="wp-block-heading">High mining costs</h4>
Cango first announced its plans to purchase $400 million worth of mining machines in November, and completed the first tranche of that the same month with its acquisition of $250 million worth. The company currently operates more than 138,000 machines in the U.S., East Africa, Oman, Paraguay and Canada, with the U.S. hosting about 40% of its capacity.
That operation began mining in mid-November, minting 363.9 bitcoins that month and another 569.9 in December. It minted another 538.2 bitcoins in January and 472.2 in February. Over that period, its production fell from 18.4 bitcoins mined each day in December to 16.9 in February, reflecting the growing competition for new bitcoins that are created at a constant rate by an algorithm no matter how many people are engaged in mining.
The company's output should soon get a one-time boost, as Cango disclosed it expects to complete its acquisition of the remaining $150 million worth of mining machines by the end of this month. CEO Lin Jiayuan said Cango will focus on installing and operating that capacity in the first half of this year, and also improving its efficiency.
The company said its cost for mining each bitcoin, excluding depreciation of its mining machines, was $67,769.90 in the fourth quarter. While that's below the current industry average of about $86,000, according to the website MacroMicro, it's still quite a bit higher than Mara's $51,035 in its latest financial report. Cango noted that the new installations will raise its capacity from the current 32 exahashes (EH) to 50 EH, making it the world's second-biggest listed miner behind only Mara.
An important reason for its higher cost-per-bitcoin mined is Cango's capital-light business model, whereby it installs its machines at existing facilities built by others. By comparison, Mara and many others build their own mining facilities, requiring far more capital but significantly lowering electricity costs that are one of their biggest expenses. Cango also has lower depreciation costs through its use of second-hand mining machines, unlike others like Mara, which use new machines.
"In the second half (of 2025), we will pursue a hash rate expansion strategy, actively seeking valuable assets to increase our overall capacity," Lin said on Cango's investor call, suggesting that even more expansion could be coming.
In terms of operating costs, the rapid bitcoin business buildup was most evident in Cango's general and administrative expenses, which nearly tripled to 127.9 million yuan in the fourth quarter from 45.6 million yuan a year earlier. But the huge jump in revenue was more than enough to offset that, with the company reporting a 55.9 million yuan profit, reversing a 103.8 million yuan loss a year earlier.
Cango also commented on its older auto businesses, including its progress in winding down its original auto financing business. It also disclosed that its newest international business expected to make its first sales of about $15 million this year through the export 1,500 cars.
The company also discussed some of the steps it is taking to control risk related to price fluctuations, including its establishment of a "comprehensive market monitoring protocol and a robust policy analysis mechanism." On the regulatory front, one of the company's most immediate risks could be its base in China, where cryptocurrency is officially banned, even though all Cango's mining operations are outside the country. In that regard, it could ultimately follow many of its formerly Chinese peers by moving its headquarters overseas, with Singapore as one of the most popular destinations for such relocations.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Cango's Fortunes Turn Around Following Move Into Bitcoin Mining

Citigroup analyst Jason Gursky initiates coverage on Karman Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRMN#NYSE">KRMN</a>) with a Buy rating and announces Price Target of $42.

Initiation

KRMN

Citigroup Initiates Coverage On Karman Holdings with Buy Rating, Announces Price Target of $42

Citigroup analyst Ariel Rosa upgrades Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from Sell to Neutral and announces $53 price target.

Citigroup Upgrades Knight-Swift to Neutral, Announces $53 Price Target

Press Releases

Paysafe to Release Third Quarter 2024 Earnings Results on November 13

Paysafe Partners with Deutsche Bank to Strengthen Its Cash Services for Postbank Customers in Germany

Paysafe Reports Third Quarter 2024 Results; Reaffirms Full Year Outlook

Small Cap

Copa Airlines Unveils New Support for Key Alternative Payment Methods in Partnership with UATP

Paysafe Expands Payment Options Business to Brazil

Global Bettors Demand Payment Choice, Speed, and Security in Play

Paysafe Announces Agreement to Sell Direct Marketing Payment Processing Business Line

Paysafe to Release Fourth Quarter and Full Year 2024 Earnings Results on March 4

Comments

Paysafe

뉴스

파트너 / 기고자

벤징가 글로벌